Altavant Sciences, Inc, based in Cary, NC, is dedicated to improving global health by driving innovative treatments in critical areas such as psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell gene therapy. Their diverse pipeline of preclinical and clinical programs aims to deliver patient-first solutions through a technology-driven approach.
As a U.S. subsidiary of Sumitomo Pharma Co., Ltd., Altavant Sciences, Inc, embodies the bold promise of combining technology and life-sciences expertise to measurably improve patient outcomes. Their focus on innovation and growth in drug discovery, development, and commercialization reflects a commitment to addressing humanity's evolving health needs.
Generated from the website